THE SUPERIORITY OF CCNU IN THE TREATMENT OF ADVANCED HODGKINS-DISEASE - CANCER AND LEUKEMIA GROUP-B STUDY

被引：0
|
作者：
HANSEN, HH
SELAWRY, OS
PAJAK, TF
SPURR, CL
FALKSON, G
BRUNNER, K
CUTTNER, J
NISSEN, NI
HOLLAND, JF
机构：
[1] UNIV MIAMI,MIAMI,FL 33152
[2] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27103
[3] CUNY MT SINAI SCH MED,NEW YORK,NY 10029
[4] HF VERWOERD,PRETORIA,SOUTH AFRICA
[5] STAT OFF,CANC & LEUKEMIA GRP B,SCARSDALE,NY
来源：
CANCER | 1981年 / 47卷 / 01期
关键词：
D O I：
10.1002/1097-0142(19810101)47:1<14::AID-CNCR2820470103>3.0.CO;2-Y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：14 / 18
页数：5
相关论文
共 50 条
  • [41] MOPP VS MOPP ALTERNATING WITH STREPTOZOTOCIN, CCNU, ADRIAMYCIN AND BLEOMYCIN (SCAB) FOR ADVANCED HODGKINS-DISEASE
    WIERNIK, PH
    LONGO, D
    DUFFEY, PL
    YOUNG, RC
    DEVITA, VT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 159 - 159
  • [42] POPULATION PHARMACODYNAMIC STUDY OF AMONAFIDE - A CANCER AND LEUKEMIA GROUP-B STUDY
    RATAIN, MJ
    ROSNER, G
    ALLEN, SL
    COSTANZA, M
    VANECHO, DA
    HENDERSON, IC
    SCHILSKY, RL
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) : 741 - 747
  • [43] PHASE-II STUDY OF 5-FLUOROURACIL, METHYL-CCNU, AND DAUNORUBICIN IN COLORECTAL-CANCER - CANCER AND LEUKEMIA GROUP-B STUDY
    WHITE, LA
    PERRY, MC
    KARDINAL, CG
    KENNEDY, BJ
    WEISS, RB
    CAREY, RW
    CANCER TREATMENT REPORTS, 1979, 63 (02): : 215 - 217
  • [44] CAV CHEMOTHERAPY (CCNU, MELPHALAN, ETOPOSIDE) AS SALVAGE TREATMENT FOR RELAPSING OR RESISTANT HODGKINS-DISEASE
    BRUSAMOLINO, E
    CASTELLI, G
    PAGNUCCO, G
    ORLANDI, E
    MALAGO, D
    LAZZARINO, M
    BERNASCONI, C
    HAEMATOLOGICA, 1990, 75 (04) : 340 - 345
  • [45] TREATMENT OF ADVANCED HODGKINS-DISEASE WITH LOMUSTINE, ETOPOSIDE, AND PREDNIMUSTINE
    VONHIRSCHHAUSEN, R
    STEINKE, B
    SAAL, JG
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (06) : 768 - 769
  • [46] ALTERNATING CHEMOTHERAPY AND IRRADIATION IN THE TREATMENT OF ADVANCED HODGKINS-DISEASE
    HOPPE, RT
    PORTLOCK, CS
    GLATSTEIN, E
    ROSENBERG, SA
    KAPLAN, HS
    CANCER, 1979, 43 (02) : 472 - 481
  • [47] TREATMENT OF 49 UNRANDOMIZED PATIENTS WITH ADVANCED HODGKINS-DISEASE
    CHISESI, T
    RICCIARDI, O
    DALFIOR, S
    CAPPELLARI, F
    POZZA, F
    BATTISTA, R
    CORTELAZZO, S
    CAPNIST, G
    DEMILIO, A
    RODEGHIERO, F
    DINI, E
    TUMORI, 1983, 69 (05) : 463 - 467
  • [48] CAN MOPP BE REPLACED IN THE TREATMENT OF ADVANCED HODGKINS-DISEASE
    CANELLOS, GP
    SEMINARS IN ONCOLOGY, 1990, 17 (01) : 2 - 6
  • [49] TREATMENT OF ADVANCED HODGKINS-DISEASE IN PEDIATRIC-PATIENTS
    LANGE, B
    LITTMAN, P
    SCHNAUFER, L
    EVANS, A
    CANCER, 1978, 42 (03) : 1141 - 1145
  • [50] TREATMENT OF ADVANCED MOPP RESISTANT HODGKINS-DISEASE WITH ABVP
    OLVER, IN
    WOLF, MM
    BISHOP, JF
    DING, JC
    COOPER, IA
    MATTHEWS, JP
    MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03): : 215 - 215
12345